KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Cash from Investing Activities (2016 - 2025)

Tenet Healthcare's Cash from Investing Activities history spans 17 years, with the latest figure at -$389.0 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 4.57% year-over-year to -$389.0 million; the TTM value through Dec 2025 reached -$1.3 billion, down 137.18%, while the annual FY2025 figure was -$1.3 billion, 137.18% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$389.0 million at Tenet Healthcare, down from -$385.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $3.3 billion in Q1 2024 and bottomed at -$1.5 billion in Q4 2021.
  • The 5-year median for Cash from Investing Activities is -$190.5 million (2024), against an average of -$16.8 million.
  • The largest annual shift saw Cash from Investing Activities crashed 376.67% in 2023 before it skyrocketed 1263.64% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$1.5 billion in 2021, then skyrocketed by 79.82% to -$306.0 million in 2022, then decreased by 8.82% to -$333.0 million in 2023, then dropped by 11.71% to -$372.0 million in 2024, then fell by 4.57% to -$389.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Cash from Investing Activities are -$389.0 million (Q4 2025), -$385.0 million (Q3 2025), and -$314.0 million (Q2 2025).